Results
|
5221.
|
|
|
5222.
|
|
|
5223.
|
|
|
5224.
|
Simplified prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer: a GERCOR study. [electronic resource] by
- Chibaudel, Benoist
- Bonnetain, Franck
- Tournigand, Christophe
- Bengrine-Lefevre, Leila
- Teixeira, Luis
- Artru, Pascal
- Desramé, Jérôme
- Larsen, Annette K
- André, Thierry
- Louvet, Christophe
- de Gramont, Aimery
Producer: 20120126
In:
The oncologist vol. 16
Availability: No items available.
|
|
5225.
|
[Analysis of the correlation with KRAS gene mutation status and the benefit of cetuximab plus irinotecan as third- line chemotherapy for the Treatment of unresectable metastatic colorectal cancer]. [electronic resource] by
- Asai, Hiroaki
- Shinozaki, Eiji
- Nozaki, Akira
- Watanabe, Toshiyasu
- Suenaga, Mitsukuni
- Matuzaka, Satoshi
- Chin, Keisho
- Mizunuma, Nobuyuki
- Yasukawa, Masaki
- Hatake, Kiyohiko
Producer: 20110906
In:
Gan to kagaku ryoho. Cancer & chemotherapy vol. 38
Availability: No items available.
|
|
5226.
|
|
|
5227.
|
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer. [electronic resource] by
- Carrato, A
- Gómez, A
- Escudero, P
- Chaves, M
- Rivera, F
- Marcuello, E
- González, E
- Grávalos, C
- Constenla, M
- Manzano, J Luis
- Losa, F
- Maurel, J
- Dueñas, R
- Massuti, B
- Gallego, J
- Aparicio, J
- Antón, A
- Aranda, E
Producer: 20140324
In:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico vol. 15
Availability: No items available.
|
|
5228.
|
GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer. [electronic resource] by
- Rick, Ferenc G
- Seitz, Stephan
- Schally, Andrew V
- Szalontay, Luca
- Krishan, Awtar
- Datz, Christian
- Stadlmayr, Andreas
- Buchholz, Stefan
- Block, Norman L
- Hohla, Florian
Producer: 20130430
In:
Cell cycle (Georgetown, Tex.) vol. 11
Availability: No items available.
|
|
5229.
|
|
|
5230.
|
Multi-institutional experience with FOLFIRINOX in pancreatic adenocarcinoma. [electronic resource] by
- Peddi, Parvin F
- Lubner, Sam
- McWilliams, Robert
- Tan, Benjamin R
- Picus, Joel
- Sorscher, Steven M
- Suresh, Rama
- Lockhart, A Craig
- Wang, Jian
- Menias, Christine
- Gao, Feng
- Linehan, David
- Wang-Gillam, Andrea
Producer: 20130201
In:
JOP : Journal of the pancreas vol. 13
Availability: No items available.
|
|
5231.
|
Update on capecitabine alone and in combination regimens in colorectal cancer patients. [electronic resource] by
- Silvestris, N
- Maiello, E
- De Vita, F
- Cinieri, S
- Santini, D
- Russo, A
- Tommasi, S
- Azzariti, A
- Numico, G
- Pisconti, S
- Petriella, D
- Lorusso, V
- Millaku, A
- Colucci, G
Producer: 20110105
In:
Cancer treatment reviews vol. 36 Suppl 3
Availability: No items available.
|
|
5232.
|
CPT-11 as a second-line treatment for patients with advanced/metastatic gastric cancer who failed S-1 (CCOG0702). [electronic resource] by
- Mochizuki, Yoshinari
- Ohashi, Norifumi
- Kojima, Hiroshi
- Ishigure, Kiyoshi
- Kinoshita, Takashi
- Eguchi, Takehiko
- Fujitake, Shinichi
- Ito, Seiji
- Fujiwara, Michitaka
- Kodera, Yasuhiro
Producer: 20131023
In:
Cancer chemotherapy and pharmacology vol. 72
Availability: No items available.
|
|
5233.
|
Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial. [electronic resource] by
- Hoff, Paulo M
- Saragiotto, Daniel F
- Barrios, Carlos H
- del Giglio, Auro
- Coutinho, Anelisa K
- Andrade, Aline C
- Dutra, Carolina
- Forones, Nora M
- Correa, Mariangela
- Portella, Maria do Socorro O
- Passos, Vanessa Q
- Chinen, Renata N
- van Eyll, Brigitte
Producer: 20140529
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 32
Availability: No items available.
|
|
5234.
|
Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach. [electronic resource] by
- Ocean, Allyson J
- Christos, Paul
- Sparano, Joseph A
- Shah, Manish A
- Yantiss, Rhonda K
- Cheng, Jonathan
- Lin, Juan
- Papetti, Michael
- Matulich, Dan
- Schnoll-Sussman, Felice
- Besanceney-Webler, Christen
- Xiang, Jenny
- Ward, Maureen
- Dilts, Kaili Temple
- Keresztes, Roger
- Holloway, Shannon
- Chen, Eric X
- Wright, John J
- Lane, Maureen E
Producer: 20150207
In:
Investigational new drugs vol. 32
Availability: No items available.
|
|
5235.
|
|
|
5236.
|
Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity. [electronic resource] by
- Wallace, Bret D
- Roberts, Adam B
- Pollet, Rebecca M
- Ingle, James D
- Biernat, Kristen A
- Pellock, Samuel J
- Venkatesh, Madhu Kumar
- Guthrie, Leah
- O'Neal, Sara K
- Robinson, Sara J
- Dollinger, Makani
- Figueroa, Esteban
- McShane, Sarah R
- Cohen, Rachel D
- Jin, Jian
- Frye, Stephen V
- Zamboni, William C
- Pepe-Ranney, Charles
- Mani, Sridhar
- Kelly, Libusha
- Redinbo, Matthew R
Producer: 20160721
In:
Chemistry & biology vol. 22
Availability: No items available.
|
|
5237.
|
Circulating Tumor Cell Enumeration in a Phase II Trial of a Four-Drug Regimen in Advanced Colorectal Cancer. [electronic resource] by
- Krebs, Matthew G
- Renehan, Andrew G
- Backen, Alison
- Gollins, Simon
- Chau, Ian
- Hasan, Jurjees
- Valle, Juan W
- Morris, Karen
- Beech, Janette
- Ashcroft, Linda
- Saunders, Mark P
- Dive, Caroline
Producer: 20160209
In:
Clinical colorectal cancer vol. 14
Availability: No items available.
|
|
5238.
|
|
|
5239.
|
|
|
5240.
|
|